Kentucky has the highest cancer incidence and mortality rate in the nation, and new data shows the state ranks sixth ...

Two Tasmanian researchers tackling one of the most aggressive forms of brain cancer have been awarded scholarships by Cancer ...

CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...

An adjuvant personalized DNA vaccine caused no serious adverse events and extended overall survival in nine patients in a ...

Jason Collins, the NBA’s first openly gay player who went on to become a pioneer for inclusion and an ambassador for the ...

Jason Collins, the NBA's first openly gay player, who went on to become a pioneer for inclusion and an ambassador for the ...

A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

Participants in a clinical trial lived longer years longer after increased immune response to glioblastoma slowed progression ...